| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2024 | Dec 26, 2024 | FATE THERAPEUTICS INC | Director | Buy | 65.0 | +56,331 | 0.44% | ✗ | $94.6K |
| Dec 11, 2024 | Dec 13, 2024 | ADC Therapeutics SA | 10% Owner | Buy | 75.0 | +200,000 | 0.70% | ✗ | $609K |
| Dec 4, 2024 | Dec 6, 2024 | ADC Therapeutics SA | 10% Owner | Buy | 60.0 | +25,320 | 0.09% | ✗ | $52.4K |
| Jul 1, 2024 | Jul 3, 2024 | ADC Therapeutics SA | 10% Owner | Buy | 92.5 | +800,000 | 2.87% | ✗ | $2.2M |
| Mar 1, 2024 | Mar 5, 2024 | Absci Corp | Director | Buy | 90.0 | +222,222 | 2.77% | ✗ | $1000K |
| Dec 26, 2023 | Dec 28, 2023 | FATE THERAPEUTICS INC | Director | Buy | 60.0 | +44,630 | 0.11% | ✗ | $166K |
| Apr 20, 2023 | Apr 21, 2023 | FATE THERAPEUTICS INC | Director | Buy | 87.5 | +276,639 | 2.15% | ✗ | $1.7M |
| Apr 13, 2023 | Apr 17, 2023 | FATE THERAPEUTICS INC | Director | Sell | 27.5 | -276,639 | -0.54% | ✗ | $1.6M |
| Oct 13, 2022 | Oct 18, 2022 | Zymeworks Inc. | 10% Owner | Buy | 72.5 | +30,481 | 0.50% | ✗ | $153.4K |
| Nov 2, 2021 | Nov 4, 2021 | Entrada Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,000,000 | 104.78% | ✗ | $20M |
| Aug 10, 2021 | Aug 12, 2021 | Invivyd, Inc. | 10% Owner | Buy | 100.0 | +1,470,000 | 76.52% | ✗ | $25M |
| Jul 26, 2021 | Jul 28, 2021 | Absci Corp | Director | Buy | 100.0 | +1,875,000 | 30.46% | ✗ | $30M |
| Dec 28, 2020 | Feb 16, 2021 | Aprea Therapeutics, Inc. | 10% Owner | Sell | 17.5 | -500,000 | -22.04% | ✗ | $2.8M |
| Jan 8, 2021 | Jan 12, 2021 | FATE THERAPEUTICS INC | Director | Buy | 95.0 | +327,485 | 2.59% | ✗ | $28M |
| Oct 14, 2020 | Oct 15, 2020 | Shattuck Labs, Inc. | Director | Buy | 100.0 | +3,441,176 | 157.94% | ✗ | $59.7M |
| Jun 11, 2020 | Jun 17, 2020 | FATE THERAPEUTICS INC | Director | Buy | 100.0 | +1,412,928 | 12.60% | ✗ | $40M |
| Mar 27, 2020 | Apr 6, 2020 | Neurogene Inc. | 10% Owner | Buy | 92.5 | +174,632 | 4.52% | ✗ | $1.8M |
| Oct 7, 2019 | Oct 8, 2019 | Aprea Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +400,000 | 21.41% | ✗ | $6M |
| Sep 16, 2019 | Sep 17, 2019 | FATE THERAPEUTICS INC | Director | Buy | 97.5 | +857,143 | 8.27% | ✗ | $15M |
| Sep 25, 2018 | Sep 27, 2018 | FATE THERAPEUTICS INC | Director | Buy | 100.0 | +3,703,704 | 55.64% | ✗ | $50M |